MX9705214A - Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de hiperlipoproteinemia, hipertrigliceridemia, hiperlipidemia o hipercolesterolemia o arterioesclerosis o para el tratamiento anticoa - Google Patents

Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de hiperlipoproteinemia, hipertrigliceridemia, hiperlipidemia o hipercolesterolemia o arterioesclerosis o para el tratamiento anticoa

Info

Publication number
MX9705214A
MX9705214A MX9705214A MX9705214A MX9705214A MX 9705214 A MX9705214 A MX 9705214A MX 9705214 A MX9705214 A MX 9705214A MX 9705214 A MX9705214 A MX 9705214A MX 9705214 A MX9705214 A MX 9705214A
Authority
MX
Mexico
Prior art keywords
treatment
hyperlipoproteinaemia
hypertriglyceridaemia
hypercholesterolaemia
hyperlipidaemia
Prior art date
Application number
MX9705214A
Other languages
English (en)
Other versions
MXPA97005214A (es
Inventor
Michael Shalmi
Niels Korsgaard
Steven Bain
Birgitte Hjort Guldhammer
Jan Ulrik Weis
Charles E Hart
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of MX9705214A publication Critical patent/MX9705214A/es
Publication of MXPA97005214A publication Critical patent/MXPA97005214A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invencion proporciona el uso de compuestos novedosos de la formula general (I) en la que R1, R4 y R5 son individualmente hidrogeno, hidroxi, halogeno, trifluorometilo, alquilo inferior, alcoxi inferior o (amino terciario) (alcoxi inferior); y R2 y R3 son individualmente hidrogeno o alquilo inferior o como una sal farmacéuticamente aceptable de los mismos en combinacion con un portador farmacéuticamente aceptable para la fabricacion de una composicion farmacéutica para el tratamiento o profilaxis de hiperlipoproteinemia, hipertrigliceridemia, hiperlipidemia o hipercolesterolemia o anteriosclerosis o para el tratamiento anticoagulante.
MXPA/A/1997/005214A 1995-01-13 1997-07-10 Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de hiperlipoproteinemia, hipertrigliceridemia, hiperlipidemia o hipercolesterolemia o arterioesclerosis o para el tratamiento anticoa MXPA97005214A (es)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
DK0043/95 1995-01-13
DK4395 1995-01-13
DK0041/95 1995-01-13
DK4195 1995-01-13
DK0069/95 1995-01-20
DK6995 1995-01-20
DK0767/95 1995-06-30
DK0777/95 1995-06-30
DK0766/95 1995-06-30
DK76795 1995-06-30
DK76695 1995-06-30
DK77795 1995-06-30
PCT/DK1996/000014 WO1996021443A1 (en) 1995-01-13 1996-01-10 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative treatment

Publications (2)

Publication Number Publication Date
MX9705214A true MX9705214A (es) 1997-10-31
MXPA97005214A MXPA97005214A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
NO973241D0 (no) 1997-07-11
IL116745A (en) 1999-12-22
EP0804189A1 (en) 1997-11-05
JPH10511961A (ja) 1998-11-17
BR9606890A (pt) 1997-10-28
IL116745A0 (en) 1996-05-14
WO1996021443A1 (en) 1996-07-18
CN1168098A (zh) 1997-12-17
NO973241L (no) 1997-07-11
AU4329296A (en) 1996-07-31
CA2208859A1 (en) 1996-07-18
HUP9800521A2 (hu) 1998-12-28
CZ212397A3 (en) 1997-11-12
HUP9800521A3 (en) 1999-12-28

Similar Documents

Publication Publication Date Title
MX9700886A (es) Nuevas oxazolidinonas sustituidas.
BG106524A (en) Piperidine quinolyl propyl derivatives and their use as antibacterial means
HK1063788A1 (en) Biologically active methylene blue derivatives
MY119150A (en) Azetidine derivatives, their preparation and medicaments containing them
MX9604020A (es) Arilalquildiazinonas.
AP9701041A0 (en) Pyridylpyrrole compounds.
AU1367497A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma
NO983178L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasaytisk preparat for behandling eller profylakse av menopausesymptomer
HU9601587D0 (en) Antracycline derivatives
NO973340L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av fedme
MX9705214A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de hiperlipoproteinemia, hipertrigliceridemia, hiperlipidemia o hipercolesterolemia o arterioesclerosis o para el tratamiento anticoa
TW370460B (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative...
SE9603285D0 (sv) New compounds
ZA951963B (en) N-benzoylmethyl-piperidines
NO973242L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti
MX9705379A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis vasodilatadora.
CA2283083A1 (en) Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders
MX9705390A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de desordenes degenerativos cerebrales.
HU9500710D0 (en) Ureido-acetamide derivatives, preparation thereof and drugs containing same
MX9605415A (es) Derivado de propiofenona y procedimientos para preparar el mismo.
MX9705136A (es) Fusacandinas antifungales.
MX9802933A (es) Derivados novedosos de amina de 2", 3"-didesoxiglicosidos de epipodofilotoxina, metodo de preparacion de los mismos y uso de los mismos con un farmaco y para tratamientos anticancer.